Itraconazole — a new oral antifungal agent with a very broad spectrum of activity in superficial and systemic mycoses
- 30 April 1993
- journal article
- review article
- Published by Elsevier in Journal of Dermatological Science
- Vol. 5 (2) , 65-72
- https://doi.org/10.1016/0923-1811(93)90072-w
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Posttreatment itraconazole levels in the nailJournal of the American Academy of Dermatology, 1992
- Itraconazole therapy in aspergillosis: Study in 49 patientsJournal of the American Academy of Dermatology, 1990
- Itraconazole in tinea versicolor: A reviewJournal of the American Academy of Dermatology, 1990
- Biochemical Approaches to Selective Antifungal Activity. Focus on Azole AntifungalsMycoses, 1989
- Oral, Topical and Parenteral Antifungal Treatment with Itraconazole in Normal and in Immunocompromised AnimalsMycoses, 1989
- Itraconazole vs amphotericin B: in vitro comparative evaluation of the minimal inhibitory concentration (MIC) against clinically isolated yeastsMycopathologia, 1989
- ItraconazoleDrugs, 1989
- A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbitJournal of Antimicrobial Chemotherapy, 1987
- Inhibitory Effect of Antifungal Agents on Germ Tube Formation in Candida albicans. Hemmeffekt antifungaler Wirkstoffe auf die Keimschlauchbildung von Candida albicansMycoses, 1987
- Effects of Imidazole- and Triazole-derivative Antifungal Compounds on the Growth and Morphological Development of Candida albicans HyphaeMicrobiology, 1985